ORIFARM GROUP A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.1% 1.1% 1.1% 1.1% 1.1%  
Bankruptcy risk  0.7% 2.5% 1.7% 1.5% 1.4%  
Credit score (0-100)  95 62 72 76 76  
Credit rating  AA BBB A A A  
Credit limit (kEUR)  15,453.3 0.7 160.1 809.7 1,242.4  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kEUR) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  13,878 8,627 1,361 3,437 3,664  
Gross profit  13,891 -11,772 -681 11,650 12,836  
EBITDA  -2,903 -24,222 -22,150 -14,384 -13,528  
EBIT  -4,691 -26,109 -25,814 -20,020 -19,833  
Pre-tax profit (PTP)  34,118.0 22,335.0 20,563.0 19,281.0 12,579.0  
Net earnings  34,737.0 25,518.0 28,690.0 25,689.0 22,442.0  
Pre-tax profit without non-rec. items  34,118 22,335 20,563 19,281 12,579  

 
See the entire income statement

Balance sheet (kEUR) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  1,501 2,859 4,888 4,661 4,334  
Shareholders equity total  167,930 148,963 169,527 187,233 208,098  
Interest-bearing liabilities  96,034 191,030 627,293 779,911 851,706  
Balance sheet total (assets)  272,117 353,106 855,502 1,022,745 1,104,465  

Net Debt  96,027 191,023 627,271 779,414 851,692  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  13,878 8,627 1,361 3,437 3,664  
Net sales growth  38.6% -37.8% -84.2% 152.5% 6.6%  
Gross profit  13,891 -11,772 -681 11,650 12,836  
Gross profit growth  36.9% 0.0% 94.2% 0.0% 10.2%  
Employees  65 83 125 174 202  
Employee growth %  14.0% 27.7% 50.6% 39.2% 16.1%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  272,117 353,106 855,502 1,022,745 1,104,465  
Balance sheet change%  37.6% 29.8% 142.3% 19.5% 8.0%  
Added value  -2,903.0 -24,222.0 -22,150.0 -16,356.0 -13,528.0  
Added value %  -20.9% -280.8% -1,627.5% -475.9% -369.2%  
Investments  -744 6,562 6,639 -5,720 -7,562  

Net sales trend  2.0 -1.0 -2.0 1.0 2.0  
EBIT trend  -4.0 -5.0 -5.0 -5.0 -5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  -20.9% -280.8% -1,627.5% -418.5% -369.2%  
EBIT %  -33.8% -302.6% -1,896.7% -582.5% -541.3%  
EBIT to gross profit (%)  -33.8% 221.8% 3,790.6% -171.8% -154.5%  
Net Earnings %  250.3% 295.8% 2,108.0% 747.4% 612.5%  
Profit before depreciation and extraordinary items %  263.2% 317.7% 2,377.2% 911.4% 784.6%  
Pre tax profit less extraordinaries %  245.8% 258.9% 1,510.9% 561.0% 343.3%  
ROA %  15.3% 8.3% 6.6% 5.1% 10.4%  
ROI %  15.6% 8.5% 6.9% 5.4% 10.8%  
ROE %  22.9% 16.1% 18.0% 14.4% 11.4%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  61.7% 42.2% 19.8% 18.3% 18.8%  
Relative indebtedness %  746.9% 2,336.2% 49,637.6% 24,009.2% 24,284.3%  
Relative net indebtedness %  746.9% 2,336.1% 49,636.0% 23,994.8% 24,283.9%  
Net int. bear. debt to EBITDA, %  -3,307.9% -788.6% -2,831.9% -5,418.6% -6,295.8%  
Gearing %  57.2% 128.2% 370.0% 416.5% 409.3%  
Net interest  0 0 0 0 0  
Financing costs %  2.2% 2.5% 4.7% 4.1% 12.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.9 0.7 0.6 1.2 1.4  
Current Ratio  1.1 0.8 0.7 1.3 1.4  
Cash and cash equivalent  7.0 7.0 22.0 497.0 14.0  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.4 1.9 84.7 8.1 99.4  
Trade creditors turnover (days)  20.5 52.8 249.6 270.6 24.4  
Current assets / Net sales %  701.0% 1,701.9% 5,766.7% 8,979.2% 11,929.1%  
Net working capital  8,265.0 -39,759.0 -30,168.0 66,715.0 127,118.0  
Net working capital %  59.6% -460.9% -2,216.6% 1,941.1% 3,469.4%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  214 104 11 20 18  
Added value / employee  -45 -292 -177 -94 -67  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -45 -292 -177 -83 -67  
EBIT / employee  -72 -315 -207 -115 -98  
Net earnings / employee  534 307 230 148 111